Veradigm (NASDAQ:MDRX) Stock Price Up 5.3%

Veradigm Inc. (NASDAQ:MDRX) shares rose 5.3% during mid-day trading on Tuesday . The stock traded as high as $8.20 and last traded at $7.90. Approximately 1,367,643 shares were traded during mid-day trading, a decline of 72% from the average daily volume of 4,908,479 shares. The stock had previously closed at $7.50.

Analyst Upgrades and Downgrades

MDRX has been the subject of several recent research reports. Barclays initiated coverage on Veradigm in a research note on Wednesday, January 3rd. They issued an “equal weight” rating and a $11.00 price target for the company. Royal Bank of Canada dropped their price objective on Veradigm from $22.00 to $11.00 and set an “outperform” rating for the company in a report on Friday, January 19th. Deutsche Bank Aktiengesellschaft reaffirmed a “hold” rating and issued a $10.00 price objective (down from $15.00) on shares of Veradigm in a report on Tuesday, March 19th. Finally, StockNews.com initiated coverage on Veradigm in a report on Friday, March 22nd. They issued a “hold” rating for the company. Five equities research analysts have rated the stock with a hold rating and one has issued a buy rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $11.25.

Veradigm Trading Down 1.3 %

The business has a 50-day moving average of $8.22 and a two-hundred day moving average of $10.67.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the company. Pinebridge Investments L.P. acquired a new position in Veradigm during the 2nd quarter worth approximately $26,000. Quarry LP acquired a new position in Veradigm during the 1st quarter worth approximately $37,000. TFO Wealth Partners LLC raised its stake in Veradigm by 105,280.0% during the 4th quarter. TFO Wealth Partners LLC now owns 5,269 shares of the software maker’s stock worth $52,000 after buying an additional 5,264 shares during the period. Gladius Capital Management LP raised its stake in Veradigm by 135.0% during the 4th quarter. Gladius Capital Management LP now owns 6,245 shares of the software maker’s stock worth $66,000 after buying an additional 3,587 shares during the period. Finally, Tower Research Capital LLC TRC raised its stake in shares of Veradigm by 95.0% in the second quarter. Tower Research Capital LLC TRC now owns 5,310 shares of the software maker’s stock worth $67,000 after purchasing an additional 2,587 shares during the last quarter.

About Veradigm

Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.